FDA’s New SaMD Rules: De-Risking Your AI Investment Strategy
The FDA is getting much tougher on the lifecycle management of AI-driven health tools. For execs and compliance officers in digital health, this is about…
The FDA is getting much tougher on the lifecycle management of AI-driven health tools. For execs and compliance officers in digital health, this is about…
FDA clearance pathways often feel like a black box, especially for digital health startups. But for any healthcare venture capitalist or corporate strategy lead, the…
The regulatory field for medical device software is in upheaval, and if you’re a quality assurance manager or on the legal team, you need to…
The line between a health app and a regulated medical device isn’t just for lawyers to debate. For health tech founders, it’s the whole ballgame,…
The ground is shifting under AI-powered health tools, and the FDA is the one moving it. For anyone in product or reg affairs, the FDA’s…
The medical device world is changing, especially for anyone building AI health tools. The FDA’s new Quality System Regulation Amendment (QMSR) is a huge part…
New AI-powered health tools are offering incredible new ways to diagnose and treat patients. But for the developers building them, the global market is a…
Digital health regulation is changing, but not through the slow grind of formal rulemaking you’re used to. The FDA knows it can’t keep up with…
Artificial intelligence is evolving so quickly in healthcare that it’s creating both massive opportunities and a regulatory mess. The old way of getting a medical…
The way the FDA regulates AI health tools is finally catching up to reality. We’re shifting from a reactive, one-and-done clearance model to a system…